NCT07137416 clinical landscape for HER2 Positive Solid Tumors: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07144254 clinical landscape for Osteosarcoma, Recurrent: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07139470 clinical landscape for Metastatic Triple-Negative Breast Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development…

NCT07143097 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07145255 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…

NCT07148050 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07156565 clinical landscape for Refractory Soft Tissue Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07153965 clinical landscape for PD-L1 positive Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and developmen…

NCT07151586 clinical landscape for Liver metastases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07160335 clinical landscape for Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07156643 clinical landscape for Locally Advanced Soft Tissue Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…

NCT07153887 clinical landscape for Clear Cell Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.